Igor A. Zupanets
27 Pushkinska Str
Kharkiv, 61057, Ukraine
Kharkiv, 61057, Ukraine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Analgesic properties of the dry combined extract BNO 1016 in leukotriene depended hyperalgesia.
Journal: Die Pharmazie
Published: January 20, 2022
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.
Journal: Journal of hepatology
Published: November 12, 2020
Histomorphological Study of a New Nasal Spray with Anti-inflammatory Properties Efficacy in Rabbits with Rhinosinusitis.
Journal: Medical archives (Sarajevo, Bosnia and Herzegovina)
Published: April 23, 2020
The hepatoprotective effect of the combination of glucosamine derivatives with quercetin against methotrexate-induced liver toxicity.
Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Published: January 01, 2020
Nephroprotective effect of N-acetylglucosamine in rats with acute kidney injury.
Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Published: December 12, 2019
Introduction of open visiting policy in intensive care units in Ukraine: policy analysis and the ethical perspective.
Journal: Asian bioethics review
Published: November 07, 2017
The Modification of Anti-Inflammatory Properties of the Combined use of Nsaids and Glucosamine in Topical Dosage Form for Degenerative and Inflammatory Joint Diseases Treatment.
Journal: Clinical therapeutics
Published: September 28, 2016
Diclocor is superior to diclofenac sodium and quercetin in normalizing biochemical parameters in rats with collagen-induced osteoarthritis.
Journal: Inflammopharmacology
Published: October 07, 2015
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.
Journal: Annals of the rheumatic diseases
Published: October 24, 2013
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
Journal: Hepatology (Baltimore, Md.)
Published: April 03, 2013
Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration.
Journal: Clinical pharmacology in drug development
Published: August 28, 2012
Last Updated: 09/26/2026